[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content

Advertisement

Log in

The in vitro susceptibility of Campylobacter spp. to the antibacterial effect of manuka honey

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

We report the antimicrobial effect of manuka honey against Campylobacter spp. isolated by a diagnostic laboratory from specimens from a community in New Zealand. The isolates were differentiated according to species level using multiplex PCR. C. jejuni (20 strains) and C. coli (7 strains) were identified. The clinical isolates identified and type culture collection strains of these species were subjected to testing to determine the minimum inhibitory concentration (MIC) of manuka honey using a microdilution technique. The MIC of the manuka honey against all of the Campylobacter tested was found to be around 1% (v/v) honey. The low MIC values suggest that honey might still inhibit the growth of campylobacteria after dilution by fluid in the gut, but the actual concentration of honey that can be achieved in the intestine is unknown. Therefore, clinical investigation is required to establish the efficacy of honey against Campylobacter spp. in the gut environment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Allos BM (2001) Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 32(8):1201–1206 doi:10.1086/319760

    Article  PubMed  CAS  Google Scholar 

  2. Meldrum RJ, Smith RM, Wilson IG (2006) Three-year surveillance program examining the prevalence of Campylobacter and Salmonella in whole retail raw chicken. J Food Prot 69(4):928–931

    PubMed  CAS  Google Scholar 

  3. Institute of Environmental Science and Research (2006) Notifiable and other diseases in New Zealand—annual report 2005. Population and Environmental Health Group, Institute of Environmental Science and Research, pp 1–56

  4. Robinson DA (1981) Infective dose of Campylobacter jejuni in milk. Br Med J (Clin Res Ed) 282:1584

    CAS  Google Scholar 

  5. Wallis MR (1994) The pathogenesis of Campylobacter jejuni. Br J Biomed Sci 51(1):57–64

    PubMed  CAS  Google Scholar 

  6. Meyer A, Stallmach T, Goldenberger D, Altwegg M (1997) Lethal maternal sepsis caused by Campylobacter jejuni: pathogen preserved in placenta and identified by molecular methods. Mod Pathol 10(12):1253–1256

    PubMed  CAS  Google Scholar 

  7. Peetermans WE, De Man F, Moerman P, van de Werf F (2000) Fatal prosthetic valve endocarditis due to Campylobacter fetus. J Infect 41(2):180–182 doi:10.1053/jinf.2000.0699

    Article  PubMed  CAS  Google Scholar 

  8. Ang CW, Jacobs BC, Laman JD (2004) The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol 25(2):61–66 doi:10.1016/j.it.2003.12.004

    Article  PubMed  CAS  Google Scholar 

  9. Smith JL (2002) Campylobacter jejuni infection during pregnancy: long-term consequences of associated bacteremia, Guillain-Barré syndrome, and reactive arthritis. J Food Prot 65(4):696–708

    PubMed  Google Scholar 

  10. Delsol AA, Sunderland J, Woodwared MJ, Pumbwe L, Piddock LJV, Roe JM (2004) Emergence of fluoroquinolone resistance in the native Campylobacter coli population of pigs exposed to enrofloxacin. J Antimicrob Chemother 53:872–874 doi:10.1093/jac/dkh150

    Article  PubMed  CAS  Google Scholar 

  11. Padungton P, Kaneene JB (2003) Campylobacter spp in human, chickens, pigs and their antimicrobial resistance. J Vet Med Sci 65(2):161–170 doi:10.1292/jvms.65.161

    Article  PubMed  Google Scholar 

  12. Takayama S, Satake S, Ishihara K (2005) Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli isolated from human diarrheic samples. Kansenshogaku Zasshi 79(3):169–175

    PubMed  Google Scholar 

  13. van Boven M, Veldman KT, de Jong MCM, Mevius DJ (2003) Rapid selection of quinolone resistance in Campylobacter jejuni but not in Escherichia coli in individually housed broilers. J Antimicrob Chemother 52(4):719–723 doi:10.1093/jac/dkg402

    Article  PubMed  CAS  Google Scholar 

  14. Haffejee IE, Moosa A (1985) Honey in the treatment of infantile gastroenteritis. Br Med J (Clin Res Ed) 290(6485):1866–1867

    Article  CAS  Google Scholar 

  15. Rolfe RD (2000) The role of probiotic cultures in the control of gastrointestinal health. J Nutr 130:396S–402S

    PubMed  CAS  Google Scholar 

  16. Molan PC (1992) The antibacterial activity of honey. I. The nature of the antibacterial activity. Bee World 73(1):5–28

    Google Scholar 

  17. Adebolu TT (2005) Effect of natural honey on local isolates of diarrhea-causing bacteria in southwestern Nigeria. Afr J Biotechnol 4(10):1172–1174

    Google Scholar 

  18. Molan PC (1992) The antibacterial activity of honey. II. Variation in the potency of the antibacterial activity. Bee World 73(2):59–76

    Google Scholar 

  19. Allen KL, Molan PC, Reid GM (1991) A survey of the antibacterial activity of some New Zealand honeys. J Pharm Pharmacol 43(12):817–822

    PubMed  CAS  Google Scholar 

  20. Molan PC, Betts JA (2004) Clinical usage of honey as a wound dressing: an update. J Wound Care 13(9):353–356

    PubMed  CAS  Google Scholar 

  21. Shannon IL, Edmonds EJ, Madsen KO (1979) Honey: sugar content and cariogenicity. ASDC J Dent Child 46(1):29–33

    PubMed  CAS  Google Scholar 

  22. National Committee for Clinical Laboratory Standards (2002) Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals: approved standard (M31-A2). NCCLS, Wayne, PA

    Google Scholar 

  23. Silley P (2003) Campylobacter and fluoroquinolones: a bias data set? Environ Microbiol 5(4):219–230 doi:10.1046/j.1462-2920.2003.00425.x

    Article  PubMed  CAS  Google Scholar 

  24. Bolton FJ, Coates D, Hutchinson DN (1984) The ability of Campylobacter media supplements to neutralize photochemically induced toxicity and hydrogen peroxide. J Appl Bacteriol 56(1):151–157

    PubMed  CAS  Google Scholar 

  25. Corry JEL, Post DE, Laisney MJ (1995) Culture media for the isolation of Campylobacters. Int J Food Microbiol 26:43–76 doi:10.1016/0168-1605(95)00044-K

    Article  PubMed  CAS  Google Scholar 

  26. Allen KL, Molan PC, Reid GM (1991) The variability of the antibacterial activity of honey. Apiacta XXVI:114–121

    Google Scholar 

  27. George HA, Hoffman PS, Smibert RM, Krieg NR (1978) Improved media for growth and aerotolerance of Campylobacter fetus. J Clin Microbiol 8(1):36–41

    PubMed  CAS  Google Scholar 

  28. Gorman R, Adley CC (2004) An evaluation of five preservation techniques and conventional freezing temperatures of –20 degrees C and −85 degrees C for long-term preservation of Campylobacter jejuni. Lett Appl Microbiol 38:306–310 doi:10.1111/j.1472-765X.2004.01490.x

    Article  PubMed  CAS  Google Scholar 

  29. Ribeiro CD, Marks J, Grimshaw AD (1985) Economic cultivation of “thermophilic” Campylobacter spp. J Clin Pathol 38(11):1311–1312 doi:10.1136/jcp.38.11.1311

    Article  PubMed  CAS  Google Scholar 

  30. Wang G, Clark CG, Taylor TM, Pucknell C, Barton C, Price L et al (2002) Colony multiplex PCR assay for identification and differentiation of Campylobacter jejuni, C. coli, C. lari, C. upsaliensis, and C. fetus subsp. fetus. J Clin Microbiol 40(12):4744–4747 doi:10.1128/JCM.40.12.4744-4747.2002

    Article  PubMed  CAS  Google Scholar 

  31. Jett BD, Hatter KL, Huycke MM, Gilmore MS (1997) Simplified agar plate method for quantifying viable bacteria. Biotechniques 23(4):648–650

    PubMed  CAS  Google Scholar 

  32. R Development Core Team (2007) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna

    Google Scholar 

  33. Cooper RA, Halas E, Molan PC (2002) The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns. J Burn Care Rehabil 23(6):366–370 doi:10.1097/00004630-200211000-00002

    Article  PubMed  CAS  Google Scholar 

  34. Cooper RA, Molan PC, Harding KG (2002) The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol 93:857–863 doi:10.1046/j.1365-2672.2002.01761.x

    Article  PubMed  CAS  Google Scholar 

  35. French VM, Cooper RA, Molan PC (2005) The antibacterial activity of honey against coagulase-negative staphylococci. J Antimicrob Chemother 56(1):228–231 doi:10.1093/jac/dki193

    Article  PubMed  CAS  Google Scholar 

  36. Natarajan S, Williamson D, Grey J, Harding KG, Cooper RA (2001) Healing of an MRSA-colonized, hydroxyurea-induced leg ulcer with honey. J Dermatolog Treat 12:33–36 doi:10.1080/095466301750163563

    Article  PubMed  CAS  Google Scholar 

  37. Al Somal N, Coley KE, Molan PC, Hancock BM (1994) Susceptibility of Helicobacter pylori to the antibacterial activity of manuka honey. J R Soc Med 87:9–12

    PubMed  Google Scholar 

  38. Cooper RA, Molan PC, Harding KG (1999) Antibacterial activity of honey against strains of Staphylococcus aureus from infected wounds. J R Soc Med 92(6):283–285

    PubMed  CAS  Google Scholar 

  39. Doyle MP, Roman DJ (1982) Response of Campylobacter jejuni to sodium chloride. Appl Environ Microbiol 43(3):561–565

    PubMed  CAS  Google Scholar 

  40. Reezal A, McNeil B, Anderson JG (1998) Effect of low-osmolality nutrient media on growth and culturability of Campylobacter species. Appl Environ Microbiol 64(12):4643–4649

    PubMed  CAS  Google Scholar 

  41. Cuccurullo SJ (2004) Physical medicine and rehabilitation board review. Demos Medical Publishing, New York

    Google Scholar 

  42. Adams CJ, Boult CH, Deadman BJ, Farr JM, Grainger MN, Manley-Harris M et al (2008) Isolation by HPLC and characterisation of the bioactive fraction of New Zealand manuka (Leptospermum scoparium) honey. Carbohydr Res 343(4):651–659 doi:10.1016/j.carres.2007.12.011

    Article  PubMed  CAS  Google Scholar 

  43. Mavric E, Wittmann S, Barth G, Henle T (2008) Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res 52(4):483–489 doi:10.1002/mnfr.200700282

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank Chris Pickett and the staff of Medlab, Hamilton, New Zealand, for advice and for the provision of the campylobacteria cultures.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. M. Lin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, S.M., Molan, P.C. & Cursons, R.T. The in vitro susceptibility of Campylobacter spp. to the antibacterial effect of manuka honey. Eur J Clin Microbiol Infect Dis 28, 339–344 (2009). https://doi.org/10.1007/s10096-008-0630-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-008-0630-3

Keywords

Navigation